FARALLON CAPITAL MANAGEMENT LLC
Position in TNGX — Tango Therapeutics, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$383,779,020
+$193,461,182 QoQ
Shares Held
12,277,000
+35.0% QoQ
Ownership
7.28%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#4
of 247 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. TNGX ranks #6 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
This page
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in TNGX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $508,606,045 | 16,270,187 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $383,779,020 | 12,277,000 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $190,317,838 | 9,097,411 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $115,724,101 | 13,061,411 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $90,358,800 | 10,757,000 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $46,883,840 | 9,157,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $6,316,974 | 4,610,930 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $12,360,000 | 4,000,000 | Shares | Other | 2025-02-14 | |
| 2022-12-31 | $1,957,500 | 270,000 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $1,086,000 | 300,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,359,000 | 300,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $2,274,000 | 300,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $3,282,000 | 300,000 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $3,879,000 | 300,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 BCTG | — | 300,000 | Shares | Other | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||